Connection

Roberto Caporali to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications Roberto Caporali has written about Antibodies, Monoclonal.
Roberto Caporali
Connection Strength
0.222
Antibodies, Monoclonal
  1. Two-year persistence of golimumab as second-line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: real-life data from the LORHEN registry. Int J Rheum Dis. 2018 Feb; 21(2):422-430.
    View in: PubMed
    Score: 0.179
  2. Two-year retention rate of golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: data from the LORHEN registry. Clin Exp Rheumatol. 2017 Sep-Oct; 35(5):804-809.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.